Each "ACCOY Drug" ensures the drug is efficactious for the patient, controls dose dispensing (compliance), prevents dose-medicated adverse events, prevents accidental ingestion, and delivers a measureable clinical outcome.  It is as if the prescriber or pharmacist was screening the patient prior to dispensing a prescribed dose.  Each ACCOY Drug is approved as a drug + DTx (ACCOY System) combination drug via the NDA 505(b)(2) pathway.  Patents and regulatory protection will extend beyond 2040. 

ACCOY drugs represent a paradigm shift from selling a drug to selling a measurable outcome.  



Combining the ACCOY System with existing or pipeline drugs enables the development of novel ACCOY therapies that go beyond the drug to empower medication and patient management at the point of care ... we call this "Point of Care Pharmacy".